We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
-5%
1 Year Est. Return
+31.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$59.9M
AUM Growth
-$31M
Cap. Flow
-$24.7M
Cap. Flow %
-41.32%
Top 10 Hldgs %
18.15%
Holding
175
New
1
Increased
36
Reduced
16
Closed
66

Top Sells

Rank Stock Value
1
MMSI icon
Merit Medical Systems
MMSI
+$1.01M
2
BLMN icon
Bloomin' Brands
BLMN
+$916K
3
EXLS icon
EXL Service
EXLS
+$884K
4
BOX icon
Box
BOX
+$868K
5
IRMD icon
iRadimed
IRMD
+$841K

Sector Composition

Rank Sector Weight
1 Technology 26.82%
2 Healthcare 22.97%
3 Consumer Discretionary 14.87%
4 Financials 8.81%
5 Industrials 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNA icon
76
Ginkgo Bioworks
DNA
$528M
$330K 0.55%
4,552
TKO icon
77
TKO Group
TKO
$13.6B
$318K 0.53%
+3,784
New +$351K
MDGL icon
78
Madrigal Pharmaceuticals
MDGL
$10.8B
$312K 0.52%
2,139
GH icon
79
Guardant Health
GH
$21.7B
$309K 0.52%
10,422
P
80
Everpure Inc
P
$25.7B
$307K 0.51%
8,605
FLWS icon
81
1-800-Flowers.com
FLWS
$250M
$304K 0.51%
43,428
PHR icon
82
Phreesia
PHR
$663M
$295K 0.49%
15,771
SLP icon
83
Simulations Plus
SLP
$369M
$291K 0.49%
6,983
ENOV icon
84
Enovis
ENOV
$1.68B
$287K 0.48%
5,446
SPT icon
85
Sprout Social
SPT
$516M
$283K 0.47%
5,668
EXAS
86
DELISTED
Exact Sciences
EXAS
$280K 0.47%
4,110
GTLB icon
87
GitLab
GTLB
$5.83B
$280K 0.47%
6,194
CSTL icon
88
Castle Biosciences
CSTL
$855M
$280K 0.47%
16,554
COHR icon
89
Coherent
COHR
$51.4B
$268K 0.45%
8,203
TFIN icon
90
Triumph Financial Inc
TFIN
$1.81B
$263K 0.44%
4,053
FIVE icon
91
Five Below
FIVE
$12B
$252K 0.42%
1,565
THO icon
92
Thor Industries
THO
$3.9B
$247K 0.41%
2,596
TDOC icon
93
Teladoc Health
TDOC
$1.22B
$239K 0.4%
12,881
ALGT icon
94
Allegiant Air
ALGT
$2.64B
$239K 0.4%
3,112
FROG icon
95
JFrog
FROG
$9.66B
$211K 0.35%
8,320
CERS icon
96
Cerus
CERS
$433M
$210K 0.35%
129,404
RLAY icon
97
Relay Therapeutics
RLAY
$4.1B
$203K 0.34%
24,117
ACAD icon
98
Acadia Pharmaceuticals
ACAD
$4.43B
$202K 0.34%
9,686
-9,686
-50% -$263K
VET icon
99
Vermilion Energy
VET
$1.82B
$202K 0.34%
13,783
-34,545
-71% -$486K
PACB icon
100
Pacific Biosciences
PACB
$435M
$197K 0.33%
23,575

Similar funds

Capital Impact Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Capital Impact Advisors held 175 positions worth $59.9M, down 34% from $90.9M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Capital Impact Advisors withdrew a net $24.7M in Q3 2023, closing 66 positions and reducing 16 holdings. Its most notable exit was Merit Medical Systems, an estimated $1.01M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Capital Impact Advisors opened a new position in TKO Group worth $318K.

  • Capital Impact Advisors's largest Q3 2023 buy was TKO Group: 3,784 shares worth $318K.
  • Capital Impact Advisors added most to Fastly Inc in Q3 2023, an estimated $903K increase.
  • Capital Impact Advisors's biggest Q3 2023 reduction was Vermilion Energy, cutting an estimated $486K.
  • Capital Impact Advisors fully exited Merit Medical Systems in Q3 2023, selling an estimated $1.01M.
  • Capital Impact Advisors's ten largest holdings make up 18% of its $59.9M portfolio in Q3 2023.
  • Capital Impact Advisors opened 1 new position and closed 66 in Q3 2023.
  • Capital Impact Advisors's portfolio value fell 34% quarter-over-quarter to $59.9M.

Based on Capital Impact Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.